peopleInnovationCareers RarePipelineCollaborationFinanceAdvance treatment Skip to main contentSkip to navigationSkip to search
HNSA   ( ,  %) SEK
Quotes are delayed 15 minutes

Birgit Stattin Norinder appointed new chairman of Hansa Medical’s board of directors

1 Oct 2014, 13:01
Regulatory information
Hansa Medical’s board of directors has named Birgit Stattin Norinder as its new chairman. 

Birgit Stattin Norinder is a member of the board of directors since 2012. She was appointed chairman of the board after Hansa Medical’s founder and previous chairman of the board Bo Håkansson passed away following a tragic accident.

Birgit Stattin Norinder has extensive experience from international Pharmaceutical and Biotechnology companies. She has held several senior Research and Development positions in Swedish, UK and US based Pharmaceutical companies including Pharmacia & Upjohn, Glaxo Group Research and Astra Research Centre. She has been Chief Executive Officer and Chairman of Prolifix Ltd. Birgit Stattin Norinder has also held several board and chairman positions of Swedish, Norwegian and other European Biotechnology companies. She is currently a member of the board of directors of Exini Diagnostics AB (publ) and Nicox S.A (publ).

For further information, please contact Hansa Medical:
Birgit Stattin Norinder, Chairman of the board of directors
Mobile: +46 706 62 61 80

Emanuel Björne, CEO
Mobile: +46 707 17 54 77

The information in this press release is such information that Hansa Medical AB (publ) is obliged to disclose under the Securities Market Act and/or the Financial Instruments Trading Act. The information was made public on October 1, 2014 at 13:00 am CET.